BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
50.38
+1.29 (2.63%)
At close: Aug 13, 2025, 4:00 PM
50.46
+0.08 (0.16%)
After-hours: Aug 13, 2025, 7:52 PM EDT
BridgeBio Pharma Employees
As of December 31, 2024, BridgeBio Pharma had 730 total employees, including 725 full-time and 5 part-time employees. The number of employees increased by 174 or 31.29% compared to the previous year.
Employees
730
Change (1Y)
174
Growth (1Y)
31.29%
Revenue / Employee
$323,030
Profits / Employee
-$1,063,582
Market Cap
9.63B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
BBIO News
- 4 days ago - BridgeBio Pharma, Inc. (BBIO) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - BridgeBio Reports Second Quarter 2025 Financial Results and Business Updates - GlobeNewsWire
- 14 days ago - Biotech Has Been Stalling. 3 Stocks That Could See Healthy Gains. - Barrons
- 21 days ago - Novel Human Genetics Evidence Confirms Estimates of Genetic Prevalence, Underdiagnosis, and Potentially Greater Symptom Burden of Gain-of-Function CASR Variants Associated with ADH1 - GlobeNewsWire
- 22 days ago - BridgeBio to Host Second Quarter 2025 Financial Results Conference Call on Tuesday, August 5, 2025 at 4:30 pm ET - GlobeNewsWire
- 6 weeks ago - BridgeBio Raises $300 Million Through Partial Capped Monetization of BEYONTTRA® European Royalty - GlobeNewsWire
- 6 weeks ago - BridgeBio to Host Limb-girdle Muscular Dystrophy Type 2I/R9 Investor Webinar on Friday, July 11th at 8:00 am ET - GlobeNewsWire
- 2 months ago - BridgeBio: New Data Bolsters The Bull Case - Seeking Alpha